According to our (Global Info Research) latest study, the global Single-cell Sequencing Systems market size was valued at US$ 926 million in 2025 and is forecast to a readjusted size of US$ 2340 million by 2032 with a CAGR of 9.8% during review period.
In 2025, the global production of single-cell sequencing systems reached approximately 1,200 units. A single-cell sequencing system is a high-throughput, precise biological analysis instrument capable of sequencing the genome, transcriptome, or epigenome at the individual cell level, enabling accurate analysis of cellular heterogeneity, rare cell populations, and dynamic biological processes. The system typically integrates microfluidic chip technology, high-sensitivity capture modules, automated liquid handling platforms, and high-throughput sequencing interfaces, allowing the isolation, lysis, and amplification of single cells for simultaneous sequencing of thousands to tens of thousands of cells. Single-cell sequencing systems are widely applied in basic life sciences research, tumor immune microenvironment analysis, stem cell studies, neuroscience, early disease diagnostics, and drug development, providing a critical tool for uncovering cellular functional diversity and complex biological networks. Additionally, the systems are equipped with data analysis software that performs data cleaning, noise reduction, gene expression quantification, and clustering, generating high-precision, reproducible single-cell data to support both research and clinical translation, thereby advancing precision medicine and personalized therapies.
Single-cell sequencing systems belong to the high-end life science instrument segment of biomedicine and in vitro diagnosis industries and represent a rapidly developing core track in the biotechnology field. Compared with traditional bulk sequencing technology, they can accurately capture cellular heterogeneity and make up for the low resolution defects of conventional sequencing equipment, being widely applied in tumor mechanism research, new drug development, immunotherapy, reproductive health and other precision medical scenarios. With the continuous increasing investment in global precision medicine and basic life science research, scientific research institutions and biopharmaceutical enterprises have growing demand for high-precision sequencing devices. Meanwhile, policies worldwide accelerate the domestic substitution of high-end medical devices to break the monopoly of overseas manufacturers. Currently, the global single-cell sequencing system market is still dominated by foreign leading enterprises, while domestic companies are narrowing the technical gap through continuous technological breakthroughs and expanding market shares relying on cost performance and localized services. In general, single-cell sequencing systems feature high technical barriers, diverse downstream applications and strong market demand with great scientific research and commercial value. Driven by declining sequencing costs, improved equipment automation and integration, and expanding clinical commercial scenarios, the industry will maintain rapid growth, with independent localization, integration and intellectualization as its core long-term development trends.
This report is a detailed and comprehensive analysis for global Single-cell Sequencing Systems market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Technical Principle and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Single-cell Sequencing Systems market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Single-cell Sequencing Systems market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Single-cell Sequencing Systems market size and forecasts, by Technical Principle and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global Single-cell Sequencing Systems market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Single-cell Sequencing Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Single-cell Sequencing Systems market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BEIJING BESTOPCELL CO., LTD., Lead Healthcare Technology (Guangzhou) Co., Ltd., SUZHOU DYNAMIC BIOSCIENCES CO., LTD., 10x Genomics, Becton, Dickinson and Company, Illumina, MGI Tech Co., Ltd., Singleron Biotechnologies Co., Ltd., M20 Genomics, Sartorius, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Single-cell Sequencing Systems market is split by Technical Principle and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Technical Principle, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Technical Principle
Droplet-based microfluidics systems
Microwell-based systems
Plate-based systems
Combinatorial indexing systems
Others
Market segment by Detection Target / Analyte
Single-cell transcriptome sequencing system
Single-cell genome sequencing system
Single-cell epigenomics system
Single-cell multi-omics system
Spatial transcriptomics system
Others
Market segment by Cellular Throughput
Low throughput (<1,000 cells/run)
Medium throughput (1,000–10,000 cells/run)
High throughput (10,000–40,000 cells/run)
Ultra-high throughput (>40,000 cells/run)
Others
Market segment by Application
Precision medicine / Clinical diagnostics
Drug discovery and development
Basic biology research
Others
Major players covered
BEIJING BESTOPCELL CO., LTD.
Lead Healthcare Technology (Guangzhou) Co., Ltd.
SUZHOU DYNAMIC BIOSCIENCES CO., LTD.
10x Genomics
Becton, Dickinson and Company
Illumina
MGI Tech Co., Ltd.
Singleron Biotechnologies Co., Ltd.
M20 Genomics
Sartorius
bitBiome Inc.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Single-cell Sequencing Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Single-cell Sequencing Systems, with price, sales quantity, revenue, and global market share of Single-cell Sequencing Systems from 2021 to 2026.
Chapter 3, the Single-cell Sequencing Systems competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Single-cell Sequencing Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Technical Principle and by Application, with sales market share and growth rate by Technical Principle, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Single-cell Sequencing Systems market forecast, by regions, by Technical Principle, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Single-cell Sequencing Systems.
Chapter 14 and 15, to describe Single-cell Sequencing Systems sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Single-cell Sequencing Systems. Industry analysis & Market Report on Single-cell Sequencing Systems is a syndicated market report, published as Global Single-cell Sequencing Systems Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Single-cell Sequencing Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.